Floatz logo

DEXTROSE SOLUTION

Postoperative Cognitive Dysfunction

University of MichiganSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Postoperative Cognitive Dysfunction cohort.

Asset / SponsorPhaseRating
4-((1E)-2-(6-(2-)2-(2-FLUOROETHOXY)ETHOXY)ETHOXY)PYRIDIN-3-YL)ETHENYL)-N-METHYLBENZENAMINE
University of California, San Francisco
Phase 4BB
CAFFEINE MIXTURE WITH CITRIC ACID
University of Michigan
Phase 2CCC

Same molecule, other indications

DEXTROSE SOLUTION is also rated in:

osteoarthritis, kneeDormant
BB
Indicative ·
69 / 100
View asset →
osteoarthritisDormant
BB
Indicative ·
69 / 100
View asset →
chronic pain syndromeDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →